Tieni traccia delle ultime attività di insider trading Amylyx Pharmaceuticals. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Amylyx Pharmaceuticals.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
A Amylyx Pharmaceuticals Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 91.33K azioni del valore di $1.32M, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Oct 02, 2025 | CO-CHIEF EXECUTIVE OFFICER | -29.98K | $14.38 | -$430.95K | SELL | -0.89% | 3.33M | Sep 30 | ||
Oct 02, 2025 | CHIEF LEGAL OFFICER | -8.83K | $14.58 | -$128.67K | SELL | -5.62% | 148.14K | Sep 30 | ||
Oct 02, 2025 | CHIEF FINANCIAL OFFICER | -10.56K | $14.65 | -$154.65K | SELL | -3.50% | 291.50K | Sep 30 | ||
Oct 02, 2025 | CO-CHIEF EXECUTIVE OFFICER | -29.93K | $14.35 | -$429.47K | SELL | -0.89% | 3.33M | Sep 30 | ||
Oct 02, 2025 | CHIEF MEDICAL OFFICER | -12.04K | $14.58 | -$175.52K | SELL | -6.19% | 182.34K | Sep 30 | ||
Aug 14, 2025 | CHIEF LEGAL OFFICER | -30.00K | $8.20 | -$246.15K | SELL | -16.05% | 156.97K | Aug 12 - Aug 13 | ||
Apr 02, 2025 | CHIEF FINANCIAL OFFICER | -10.90K | $3.47 | -$37.81K | SELL | -3.48% | 302.06K | Mar 31 | ||
Apr 02, 2025 | CHIEF MEDICAL OFFICER | -12.43K | $3.47 | -$43.08K | SELL | -6.01% | 194.38K | Mar 31 | ||
Apr 02, 2025 | CHIEF LEGAL OFFICER | -9.19K | $3.48 | -$31.95K | SELL | -4.66% | 187.97K | Mar 31 | ||
Apr 02, 2025 | CO-CHIEF EXECUTIVE OFFICER | -21.49K | $3.47 | -$74.48K | SELL | -0.64% | 3.36M | Mar 31 | ||
Apr 02, 2025 | CO-CHIEF EXECUTIVE OFFICER | -21.49K | $3.46 | -$74.45K | SELL | -0.64% | 3.36M | Mar 31 | ||
Mar 24, 2025 | — | 10.00K | $3.70 | $37.01K | BUY | ∞ | 10.00K | Mar 20 | ||
Mar 05, 2025 | CO-CHIEF EXECUTIVE OFFICER | -4.59K | $3.15 | -$14.48K | SELL | -0.14% | 3.20M | Mar 03 | ||
Mar 05, 2025 | CO-CHIEF EXECUTIVE OFFICER | -4.59K | $3.17 | -$14.55K | SELL | -0.14% | 3.20M | Mar 03 | ||
Mar 05, 2025 | CHIEF LEGAL OFFICER | -1.61K | $3.12 | -$5.02K | SELL | -1.19% | 133.31K | Mar 03 | ||
Feb 26, 2025 | CHIEF LEGAL OFFICER | -4.17K | $3.15 | -$13.14K | SELL | -3.00% | 134.92K | Feb 24 | ||
Feb 05, 2025 | CHIEF LEGAL OFFICER | -3.68K | $3.49 | -$12.84K | SELL | -2.58% | 139.09K | Feb 03 | ||
Feb 05, 2025 | CO-CHIEF EXECUTIVE OFFICER | -11.85K | $3.47 | -$41.11K | SELL | -0.37% | 3.20M | Feb 03 | ||
Feb 05, 2025 | CO-CHIEF EXECUTIVE OFFICER | -11.86K | $3.47 | -$41.10K | SELL | -0.37% | 3.16M | Feb 03 | ||
Jan 08, 2025 | CO-CHIEF EXECUTIVE OFFICER | -7.47K | $4.04 | -$30.20K | SELL | -0.23% | 3.18M | Jan 06 | ||
Jan 08, 2025 | CO-CHIEF EXECUTIVE OFFICER | -7.47K | $4.05 | -$30.23K | SELL | -0.23% | 3.21M | Jan 06 | ||
Dec 03, 2024 | CHIEF MEDICAL OFFICER | -5.42K | $5.54 | -$30.01K | SELL | -3.77% | 138.38K | Dec 02 | ||
Oct 02, 2024 | CO-CHIEF EXECUTIVE OFFICER | -18.59K | $3.20 | -$59.43K | SELL | -0.59% | 3.12M | Sep 30 | ||
Oct 02, 2024 | CO-CHIEF EXECUTIVE OFFICER | -18.59K | $3.20 | -$59.41K | SELL | -0.57% | 3.22M | Sep 30 | ||
Oct 02, 2024 | CHIEF MEDICAL OFFICER | -11.44K | $3.20 | -$36.56K | SELL | -7.37% | 143.80K | Sep 30 | ||
Oct 02, 2024 | CHIEF LEGAL OFFICER | -8.71K | $3.20 | -$27.84K | SELL | -5.75% | 142.77K | Sep 30 | ||
Sep 16, 2024 | CHIEF FINANCIAL OFFICER | 40.00K | $2.53 | $101.37K | BUY | 19.56% | 244.54K | Sep 12 | ||
Sep 09, 2024 | — | 50.00K | $2.13 | $106.59K | BUY | 1000.00% | 55.00K | Sep 05 | ||
Sep 05, 2024 | — | 100.00K | $2.20 | $219.80K | BUY | 13.18% | 858.57K | Sep 03 | ||
May 16, 2024 | — | 5.00K | $1.89 | $9.44K | BUY | ∞ | 5.00K | May 14 - May 15 | ||
May 16, 2024 | CHIEF LEGAL OFFICER | -10.46K | $1.88 | -$19.65K | SELL | -6.46% | 151.48K | May 15 | ||
Mar 07, 2024 | CO-CHIEF EXECUTIVE OFFICER | -4.13K | $18.73 | -$77.44K | SELL | -0.14% | 3.02M | Mar 05 | ||
Mar 07, 2024 | CO-CHIEF EXECUTIVE OFFICER | -4.13K | $18.73 | -$77.44K | SELL | -0.14% | 2.96M | Mar 05 | ||
Mar 07, 2024 | CHIEF FINANCIAL OFFICER | -1.79K | $18.73 | -$33.56K | SELL | -1.21% | 145.86K | Mar 05 | ||
Mar 07, 2024 | CHIEF LEGAL OFFICER | -1.54K | $18.73 | -$28.84K | SELL | -1.86% | 81.37K | Mar 05 | ||
Feb 27, 2024 | CHIEF LEGAL OFFICER | -2.84K | $18.76 | -$53.23K | SELL | -5.78% | 46.24K | Feb 23 | ||
Jan 11, 2024 | CO-CHIEF EXECUTIVE OFFICER | -5.84K | $16.33 | -$95.37K | SELL | -0.21% | 2.84M | Jan 09 | ||
Jan 11, 2024 | CHIEF FINANCIAL OFFICER | -2.72K | $16.33 | -$44.35K | SELL | -2.16% | 123.11K | Jan 09 | ||
Jan 11, 2024 | CO-CHIEF EXECUTIVE OFFICER | -5.84K | $16.33 | -$95.37K | SELL | -0.20% | 2.90M | Jan 09 | ||
Jan 11, 2024 | CHIEF MEDICAL OFFICER | -2.81K | $16.33 | -$45.91K | SELL | -1.35% | 205.60K | Jan 09 | ||
Dec 19, 2023 | — | 4.00K | $14.97 | $59.88K | BUY | 400.00% | 5.00K | Dec 15 | ||
Aug 17, 2023 | CHIEF LEGAL OFFICER | -6.16K | $20.88 | -$128.69K | SELL | -11.16% | 49.08K | Aug 15 | ||
May 18, 2023 | CHIEF FINANCIAL OFFICER | 0.00 | $16.91 | -$651.85K | SELL-OPTIONS | 0.00% | 75.16K | May 16 | ||
May 17, 2023 | CHIEF MEDICAL OFFICER | 0.00 | $17.36 | -$279.37K | SELL-OPTIONS | 0.00% | 208.42K | May 15 | ||
Apr 19, 2023 | CHIEF MEDICAL OFFICER | 0.00 | $15.76 | -$1.46M | SELL-OPTIONS | 0.00% | 208.42K | Apr 17 | ||
Mar 31, 2023 | 10% OWNER | -29.05K | $30.45 | -$884.51K | SELL | -0.41% | 7.00M | Mar 29 | ||
Mar 29, 2023 | 10% OWNER | -160.96K | $30.42 | -$4.90M | SELL | -2.24% | 7.03M | Mar 27 - Mar 28 | ||
Mar 23, 2023 | 10% OWNER | -63.45K | $31.91 | -$2.02M | SELL | -0.88% | 7.19M | Mar 21 | ||
Mar 20, 2023 | CO-CHIEF EXECUTIVE OFFICER | -50.00K | $31.86 | -$3.19M | SELL | -1.73% | 2.84M | Mar 16 | ||
Mar 20, 2023 | DIRECTOR | -35.00K | $31.89 | -$1.12M | SELL | -3.90% | 862.02K | Mar 16 | ||
Mar 20, 2023 | CHIEF MEDICAL OFFICER | -45.46K | $31.87 | -$1.74M | SELL | -22.25% | 158.84K | Mar 16 | ||
Mar 20, 2023 | DIRECTOR | 1.00K | $31.99 | $31.99K | BUY | ∞ | 1.00K | Mar 16 | ||
Mar 20, 2023 | CO-CHIEF EXECUTIVE OFFICER | -50.00K | $31.86 | -$3.19M | SELL | -1.73% | 2.84M | Mar 16 | ||
Mar 20, 2023 | CHIEF FINANCIAL OFFICER | -10.83K | $31.89 | -$1.04M | SELL | -31.85% | 23.18K | Mar 16 | ||
Mar 17, 2023 | 10% OWNER | -9.12K | $32.55 | -$296.92K | SELL | -0.13% | 7.25M | Mar 16 | ||
Mar 16, 2023 | 10% OWNER | -220.71K | $33.68 | -$7.43M | SELL | -2.95% | 7.26M | Mar 14 - Mar 15 | ||
Mar 06, 2023 | 10% OWNER | -50.00K | $33.75 | -$1.69M | SELL | -0.66% | 7.48M | Mar 02 | ||
Feb 28, 2023 | CHIEF LEGAL OFFICER | -3.59K | $34.49 | -$123.67K | SELL | -8.75% | 37.41K | Feb 24 | ||
Feb 28, 2023 | 10% OWNER | -50.00K | $34.73 | -$1.74M | SELL | -0.66% | 7.53M | Feb 22 | ||
Feb 24, 2023 | 10% OWNER | -100.00K | $35.78 | -$3.58M | SELL | -1.30% | 7.58M | Feb 22 - Feb 23 | ||
Jan 10, 2023 | CHIEF MEDICAL OFFICER | 2.03K | $36.30 | $73.83K | s | 1.01% | 204.30K | Jan 06 | ||
Jan 10, 2023 | CO-CHIEF EXECUTIVE OFFICER | 5.97K | $36.30 | $216.63K | s | 0.21% | 2.89M | Jan 06 | ||
Jan 10, 2023 | CHIEF FINANCIAL OFFICER | 2.66K | $36.30 | $96.48K | s | 8.48% | 34.01K | Jan 06 | ||
Jan 10, 2023 | CHIEF COMMERCIAL OFFICER | 2.40K | $36.30 | $87.23K | s | 1.13% | 214.35K | Jan 06 | ||
Jan 10, 2023 | CO-CHIEF EXECUTIVE OFFICER | 5.97K | $36.30 | $216.63K | s | 0.21% | 2.89M | Jan 06 | ||
Sep 09, 2022 | — | -1.40M | $29.80 | -$41.72M | SELL | -43.06% | 1.85M | Sep 08 - Sep 09 | ||
Jul 08, 2022 | 10% OWNER | -60.61K | $20.70 | -$1.25M | SELL | -1.02% | 5.90M | Jul 06 | ||
Jan 25, 2022 | 10% OWNER | 10.68M | $19.00 | $5.00M | BUY | ∞ | 10.68M | Jan 11 | ||
Jan 13, 2022 | — | 7.17M | $19.00 | $43.70M | BUY | ∞ | 2.30M | Jan 11 | ||
Jan 10, 2022 | DIRECTOR | 3.95K | $19.00 | $74.99K | BUY | ∞ | 3.95K | Jan 06 | ||
Jan 10, 2022 | DIRECTOR | 10.42M | $19.00 | $124.98K | BUY | ∞ | 6.58K | Jan 06 | ||
Jan 10, 2022 | DIRECTOR | 26.32K | $19.00 | $499.99K | BUY | 13.49% | 221.40K | Jan 06 | ||
Jan 10, 2022 | CHIEF COMMERCIAL OFFICER | 35.17K | $19.00 | $130.00K | BUY | 19.37% | 216.76K | Jan 06 |
Sfoglia insider trading su tutte le azioni.